BMS/Celgene Post-Merger Early R&D Strategy: Partnerships Are Still Key, Vessey Says :: Scrip
Katie Couric, Murdo Gordon, Giovanni Caforio - Murdo Gordon Photos - Zimbio
Bristol-Myers CEO Giovanni Caforio nets $18.7M in 2017 pay, a 10% raise | Fierce Pharma
Bristol Myers CEO Giovanni Caforio takes pay cut as 'human capital' metric drags down bonus | Fierce Pharma
A Big Biotech Bet Hiding in Plain Sight - WSJ
Bristol-Myers Squibb-Celgene Deal Faces Opposition and Breakup Fee
Our Leadership Team - Bristol Myers Squibb
Bristol Myers Squibb 2023 Proxy Statement
HR job moves: Meet BMS' Chief D&I Officer, | Human Resources Online
Giovanni Caforio, Bristol-Myers Squibb Co: Profile and Biography - Bloomberg Markets
10 Things You Didn't Know about Bristol Myers Squibb CEO Giovanni Caforio
Bristol Myers Squibb on Twitter: "Our CEO Giovanni Caforio will be on @BloombergTV today at 3:30 p.m. ET to discuss our progress in scientific innovation for patients with @CarolineHydeTV, @romainebostick & @RiggsReport.
Bristol-Myers Squibb Appoints Giovanni Caforio, M.D., Chief Executive Officer, Effective May 5; Lamberto Andreotti to Become Chairman | Business Wire
Highest-Paid CEOs in Pharma and Biotech: Insider Compensation Analysis
Bristol-Myers Squibb Company
Giovanni Caforio Remarks on U.S. Drug Pricing - Bristol Myers Squibb
Bristol-Myers Squibb Company
Bristol-Myers Squibb 2021 Proxy Statement
Bristol-Myers Squibb Company
Julia Ding - Devens, Massachusetts, United States | Professional Profile | LinkedIn
After 5 years, Eliquis' growth ceiling is nowhere in sight: Bristol-Myers CEO | Fierce Pharma
Bristol Myers Squibb on Twitter: "In his remarks at the China Development Forum, CEO Giovanni Caforio said the company will expand its portfolio of medicines and scientific collaborations in China over the
Our Board of Directors | Stryker
Bristol-Myers Squibb CEO on the drug pipeline, 2020 outlook and more
In Conversation: Bristol-Myers Squibb (NYSE: BMY) CEO say he likes their Bay Area footprint - San Francisco Business Times
